A detailed history of Susquehanna International Group, LLP transactions in Pulmonx Corp stock. As of the latest transaction made, Susquehanna International Group, LLP holds 44,596 shares of LUNG stock, worth $282,738. This represents 0.0% of its overall portfolio holdings.

Number of Shares
44,596
Previous 30,809 44.75%
Holding current value
$282,738
Previous $195,000 89.23%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.59 - $8.58 $77,069 - $118,292
13,787 Added 44.75%
44,596 $369,000
Q2 2024

Aug 15, 2024

SELL
$5.77 - $9.82 $179,337 - $305,215
-31,081 Reduced 50.22%
30,809 $195,000
Q1 2024

May 07, 2024

BUY
$8.71 - $14.65 $383,022 - $644,233
43,975 Added 245.46%
61,890 $573,000
Q4 2023

Feb 14, 2024

SELL
$7.89 - $13.14 $294,360 - $490,227
-37,308 Reduced 67.56%
17,915 $228,000
Q3 2023

Nov 14, 2023

SELL
$9.88 - $14.0 $267,797 - $379,470
-27,105 Reduced 32.92%
55,223 $570,000
Q2 2023

Aug 11, 2023

BUY
$10.78 - $13.65 $156,008 - $197,542
14,472 Added 21.33%
82,328 $1.08 Million
Q1 2023

May 16, 2023

BUY
$7.49 - $12.54 $88,898 - $148,837
11,869 Added 21.2%
67,856 $758,000
Q4 2022

Feb 14, 2023

BUY
$4.92 - $17.35 $197,936 - $698,007
40,231 Added 255.34%
55,987 $471,000
Q3 2022

Nov 14, 2022

SELL
$15.35 - $23.99 $1.3 Million - $2.04 Million
-84,913 Reduced 84.35%
15,756 $262,000
Q2 2022

Aug 15, 2022

SELL
$14.0 - $27.95 $1.14 Million - $2.27 Million
-81,259 Reduced 44.67%
100,669 $1.48 Million
Q1 2022

May 16, 2022

BUY
$21.13 - $35.65 $3.84 Million - $6.49 Million
181,928 New
181,928 $4.51 Million

Others Institutions Holding LUNG

About Pulmonx Corp


  • Ticker LUNG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,268,400
  • Market Cap $236M
  • Description
  • Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...
More about LUNG
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.